CureVac

CureVac

CureVac is a Tübingen-based messenger-RNA biotechnology company founded in 2000. Following its acquisition by BioNTech, it operates as a BioNTech subsidiary focused on mRNA research and development.

Key facts

Business ModelCommerce
Legal NameCureVac N.V.
Company Operating StatusAcquired
Full Address250 Summer St 3rd Fl Boston, MA 02210, USA
Previous NameCureVac B.V.
Stock SymbolCVAC
Ticker SymbolCVAC
Wellfound IDcurevac
Wikidata IDQ1144473

Contact details

Email and phone for CureVac are available to signed-in members of CliffBio.

Sign in to view